https://www.massachusettsweekly.com/article/904993962-peo-model-enables-small-employers-to-access-enterprise-level-benefits-packages Massachusetts Weekly en PressRelease 2026-04-10T22:16:58+00:00 PEO Model Enables Small Employers to Access Enterprise-Level Benefits Packages https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830583-peo-model-enterprise-level-be-2400x1260.png https://www.massachusettsweekly.com/article/905057092-alleron-expert-group-marks-six-years-of-100-client-retention-announces-expanded-cloud-services-portfolio Massachusetts Weekly en PressRelease 2026-04-11T03:26:49+00:00 Alleron Expert Group Marks Six Years of 100% Client Retention, Announces Expanded Cloud Services Portfolio https://ml.globenewswire.com/media/ZGU2ZmY4NzctZTQ5MS00NTk2LTg2MjItYWM2NGE0OTIzYmQ1LTUwMDE2MTA0Mi0yMDI2LTA0LTExLWVu/tiny/Alleron-Expert-Group.png https://www.massachusettsweekly.com/article/904990418-replimune-receives-complete-response-letter-from-the-fda-for-rp1-biologics-license-application-for-the-treatment-of-advanced-melanoma Massachusetts Weekly en PressRelease 2026-04-10T21:02:32+00:00 Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma https://ml.globenewswire.com/media/Y2ExYzg2MzEtNjQxMi00MmIyLTg5NjQtM2JhYTU0YjVkOTAwLTExMjIxMDEtMjAyNi0wNC0xMC1lbg==/tiny/Replimune-Inc-.png https://www.massachusettsweekly.com/article/904989976-spyre-therapeutics-to-host-conference-call-to-report-spy001-part-a-induction-topline-results-from-skyline-trial-in-moderate-to-severe-ulcerative Massachusetts Weekly en PressRelease 2026-04-10T20:05:00+00:00 Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026 https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.massachusettsweekly.com/article/904990021-korro-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-04-10T20:05:00+00:00 Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://www.massachusettsweekly.com/article/904919848-global-bispecific-antibodies-market-to-reach-22-3-billion-by-2030-as-immuno-oncology-innovation-and-r-d-investment-accelerate Massachusetts Weekly en PressRelease 2026-04-10T12:15:20+00:00 Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png